INOTEK PHARMACEUTICALS
Inotek Pharmaceuticals is developing molecules with novel mechanisms of action to fulfill major unmet medical needs in significant diseases of the eye. Complete loss of vision or vision impairment currently affects 3.3 million people over the age of 40 in the United States, with the most common diseases including age-related macular degeneration (AMD), glaucoma, cataract and diabetic retinopathy. With the continued aging of the population, the National Eye Institute projects that this number will grow to 5.5 million people by the year 2020.
INOTEK PHARMACEUTICALS
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
1996-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.inotekcorp.com
Total Employee:
11+
Status:
Active
Contact:
7816762115
Email Addresses:
[email protected]
Total Funding:
125.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Domain Not Resolving Apache ASP.NET IIS IIS 6 DediPath
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aprecia Pharmaceuticals
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Inspiration Biopharmaceuticals
Inspiration Biopharmaceuticals develops recombinant blood coagulation factor products for the treatment of hemophilia.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Qubit Pharmaceuticals
Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
ReSearch Pharmaceutical Services
Research Pharmaceutical Services, Inc., through its subsidiaries, provides integrated clinical development solutions and services to the
Ritter Pharmaceuticals
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Horizon Technology Finance
Horizon Technology Finance investment in Debt Financing - Inotek Pharmaceuticals
Rho Ventures
Rho Ventures investment in Venture Round - Inotek Pharmaceuticals
Pitango Venture Capital
Pitango Venture Capital investment in Debt Financing - Inotek Pharmaceuticals
MedImmune Ventures
MedImmune Ventures investment in Venture Round - Inotek Pharmaceuticals
MedImmune Ventures
MedImmune Ventures investment in Debt Financing - Inotek Pharmaceuticals
Devon Park BioVentures
Devon Park BioVentures investment in Venture Round - Inotek Pharmaceuticals
Devon Park BioVentures
Devon Park BioVentures investment in Debt Financing - Inotek Pharmaceuticals
Rho Ventures
Rho Ventures investment in Debt Financing - Inotek Pharmaceuticals
Pitango Venture Capital
Pitango Venture Capital investment in Venture Round - Inotek Pharmaceuticals
Care Capital
Care Capital investment in Venture Round - Inotek Pharmaceuticals
Official Site Inspections
http://www.inotekcorp.com Semrush global rank: 2.49 M Semrush visits lastest month: 7.07 K
- Host name: 104.21.29.70
- IP address: 104.21.29.70
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inotek Pharmaceuticals"
Inotek Pharmaceuticals
Inotek Pharmaceuticals is a privately held and funded biotechnology company focused on the discovery and development of innovative drugs to address serious diseases of the eye. Inotek …See details»
Overview - Inotek Pharmaceuticals
Inotek Pharmaceuticals is developing molecules with novel mechanisms of action to fulfill major unmet medical needs in significant diseases of the eye. Complete loss of vision or vision …See details»
Management Team - Inotek Pharmaceuticals - inotekcorp.com
Paul G. Howes President & Chief Executive Officer Rudolf A. Baumgartner, MD Executive Vice President, Chief Medical Officer William K. McVicar, PhD Executive Vice President, Chief …See details»
Inotek Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number 7816762115 Inotek Pharmaceuticals is developing molecules with novel mechanisms of action to …See details»
Inotek Pharmaceuticals - Overview, News & Similar companies
Who is Inotek Pharmaceuticals. Inotek Pharmaceuticals is developing molecules with novel mechanisms of action to fulfill major unmet medical needs in significant diseases of the eye. …See details»
Inotek Pharmaceuticals Corporation Management Team | Org Chart
Inotek Pharmaceuticals is a clinical-stage, publicly traded, biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat glaucoma …See details»
Inotek Corp Company Profile | Tarzana, CA - Dun & Bradstreet
Inotek Corp Company Profile | Tarzana, CA | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Inotek Pharmaceuticals - Craft
See insights on Inotek Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Inotek Pharmaceuticals Corporation Brings In A New President …
Aug 15, 2014 LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on ophthalmology, today announced that David. P. …See details»
Paul G. Howes - Inotek Pharmaceuticals - inotekcorp.com
Paul G. Howes President & Chief Executive Officer Mr. Howes joined Inotek in September of 2008 as the Company's President & CEO. Mr. Howes brings over 20 years of commercial strategy, …See details»
Inotek Pharmaceuticals Corporation Focuses Resources on Clinical ...
Apr 8, 2008 BEVERLY, Mass.--(BUSINESS WIRE)--Inotek announced today that the Company has focused its resources on the development of its two main clinical programs and the …See details»
Inotek, LLC Company Profile | Omaha, NE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Inotek, LLC of Omaha, NE. Get the latest business insights from Dun & Bradstreet.See details»
Inotek Pharmaceuticals - VentureRadar
Similar Companies: Cymabay Therapeutics Inc. USA Publicly Traded CymaBay Therapeutics is a clinical-stage biopharmaceutical company focused on developing and providing access to …See details»
Investors - Inotek Pharmaceuticals
Inotek pursued a unique funding strategy in its early stages. From 1997-2004, the Company was highly effective in attracting non-dilutive funding, raising over $50 million through federal and …See details»
Inotek Pharmaceuticals - R&D Chemicals
Inotek Pharmaceuticals - Company Profile. Custom Synthesis Company Profile Inotek Pharmaceuticals. Inotek Pharmaceuticals Corporation is a private, high-growth, development …See details»
Working at Inotek Pharmaceuticals - Glassdoor
See what employees say it's like to work at Inotek Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Inotek Pharmaceuticals.See details»
Careers & Benefits - Inotek Pharmaceuticals - inotekcorp.com
Thank you for your interest in Inotek Pharmaceuticals. Inotek is dedicated to creating an environment that promotes work/life balance by supporting the needs of employees. Inotek is …See details»
Inotek Pharmaceuticals Corporation Brings In A New President
Aug 13, 2014 Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals, Inc., a …See details»
Inotek Pharmaceuticals Corp. (Inotek Pharmaceuticals Corp.) - 药 …
了解Inotek Pharmaceuticals Corp. (Inotek Pharmaceuticals Corp.)公司的药物管线，治疗领域，技术平台，以及它的9项临床试验, 8篇新闻和151篇文献，疾病领域:神经系统疾病，血液及淋巴 …See details»
Scientific Approach - Inotek Pharmaceuticals
Critical care medicine (e.g., treatment of stroke, heart attack) was Inotek's discovery focus when founded nearly 20 years ago. The company identified three major pharmacologic targets for …See details»